An issue of HCA Healthcare Inc (NYSE:HCA) bonds rose 1.5% against their face value during trading on Friday following insider selling activity. The high-yield issue of debt has a 5.25% coupon and will mature on June 15, 2026. The bonds in the issue are now trading at $103.00 and were trading at $100.78 last week. Price changes in a company’s bonds in credit markets sometimes predict parallel changes in its share price. Specifically, CFO Bill B. Rutherford sold 48,462 shares of the business’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $102.42, for a total transaction of $4,963,478.04. Following the sale, the chief financial officer now directly owns 41,269 shares in the company, valued at $4,226,770.98. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Joseph A. Sowell III sold 58,175 shares of the business’s stock in a transaction on Friday, January 26th. The stock was sold at an average price of $95.00, for a total value of $5,526,625.00. Following the sale, the senior vice president now owns 40,536 shares in the company, valued at $3,850,920. The disclosure for this sale can be found here. Insiders have sold 396,106 shares of company stock worth $39,582,273 in the last ninety days. 2.90% of the stock is currently owned by corporate insiders.
A number of analysts have commented on HCA shares. Credit Suisse Group reiterated an “outperform” rating and set a $25.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 26th. Robert W. Baird set a $104.00 target price on HCA Healthcare and gave the stock a “buy” rating in a research report on Friday, January 12th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 target price on the stock. in a research report on Wednesday, December 20th. Goldman Sachs Group started coverage on HCA Healthcare in a research report on Wednesday, January 3rd. They set a “neutral” rating on the stock. Finally, Bank of America downgraded HCA Healthcare from a “neutral” rating to an “underperform” rating and decreased their target price for the stock from $94.00 to $90.00 in a research report on Thursday, January 4th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $104.50.
The company has a debt-to-equity ratio of -6.58, a quick ratio of 1.36 and a current ratio of 1.62. The firm has a market cap of $35,359.29, a PE ratio of 17.00, a PEG ratio of 1.01 and a beta of 0.48.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, January 30th. The company reported $2.12 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.87 by $0.25. HCA Healthcare had a negative return on equity of 49.49% and a net margin of 4.89%. The business had revenue of $11.56 billion for the quarter, compared to the consensus estimate of $11.19 billion. During the same period in the prior year, the business earned $1.80 earnings per share. The business’s revenue was up 8.7% on a year-over-year basis. equities analysts expect that HCA Healthcare Inc will post 8.71 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 1st will be given a $0.35 dividend. The ex-dividend date is Wednesday, February 28th. This represents a $1.40 annualized dividend and a dividend yield of 1.39%.
Large investors have recently modified their holdings of the company. Dynamic Technology Lab Private Ltd purchased a new position in HCA Healthcare during the second quarter worth about $444,000. Mutual of America Capital Management LLC lifted its position in HCA Healthcare by 2.2% during the third quarter. Mutual of America Capital Management LLC now owns 35,732 shares of the company’s stock worth $2,844,000 after buying an additional 761 shares during the period. Assenagon Asset Management S.A. lifted its position in HCA Healthcare by 1,500.3% during the third quarter. Assenagon Asset Management S.A. now owns 1,579,382 shares of the company’s stock worth $125,703,000 after buying an additional 1,480,690 shares during the period. APG Asset Management N.V. lifted its position in HCA Healthcare by 141.4% during the third quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock worth $272,467,000 after buying an additional 2,005,193 shares during the period. Finally, Strs Ohio lifted its position in HCA Healthcare by 12.2% during the third quarter. Strs Ohio now owns 1,075,778 shares of the company’s stock worth $85,621,000 after buying an additional 117,000 shares during the period. Institutional investors and hedge funds own 75.49% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.